Company: NHICW
Filing Date: 2025-01-02
Form Type: CORRESP
Source: 0001213900-25-000457
Chunk: 0

Company: NewHold Investment Corp. III
Filing Date: 2025-01-02
Form: CORRESP
Chunk 0
---
|           | Giovanni Caruso  
 Partner          
 345 Park Avenue  | Direct 
 Main   
 Fax    | 212.407.4866 
 212.407.4000 
 212.937.3943 |
| New York, 
 NY 10154  | gcaruso@loeb.com |        |              |

VIA EDGAR

January 2, 2025

Division of Corporation Finance
U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

| Attention: | Stacie Gorman    |
|            | Dorrie Yale      
 Peter McPhun     
 Kristina Marrone |

Dear Ms. Gorman:

On behalf of our client, NewHold
Investment Corp. III, a Cayman Islands exempted company (the “Company”), we hereby respond to the comments of
the staff of the Division of Corporation Finance of the Commission (the “Staff”) with respect to the above-referenced
Draft Registration Statement on Form S-1 submitted on December 5, 2024 (the “Draft Registration Statement”)
contained in the Staff’s letter dated December 19, 2024 (the “Comment Letter”). Concurrently with the
submission of this letter, the Company is publicly filing the Registration Statement on Form S-1 (the “Registration Statement”)
via EDGAR for review in accordance with the procedures of the Securities and Exchange Commission.

In order to facilitate the
review by the Staff of the Registration Statement, we have responded, on behalf of the Company, to the comments set forth in the Staff’s
Letter on a point-by-point basis. The numbered paragraphs set forth below respond to the Staff’s comments and correspond to the
numbered paragraph in the Comment Letter.

| 1. | We note your revised disclosure referencing                                                                                 
 a 30-day cure period for any applicable extension payment. Please revise as appropriate to explain the purpose of this cure 
 period.                                                                                                                     |

Response:The Company has
revised the disclosure on the cover page and on pages 32, 104, and 171 of the Registration Statement to remove the reference to the 30-day cure period as the Company does not have the option to make additional
payments to the trust account to extend the time needed to complete a business combination.

| 2. | We acknowledge your revised disclosures                                                                                                    
 in response to prior comment 1. Please also revise to add disclosure regarding the compensation to management through grants of membership 
 interests